Developer docs
API playgroundTry for free, no card

Search company profiles

Alpha Cord

Full company profile

uuid000ktpm

Namestring
Alpha Cord
Legal namestring
AlphaCord, LLC
Websiteurl
alphacord.com
Company typeenum
Private
Founded yearint
2002
Descriptiontext

AlphaCord, LLC is a privately held U.S. cord blood and tissue banking company founded in 2002 and headquartered in Scottsdale, Arizona. The company provides direct-to-consumer cryogenic preservation services for newborn stem cells sourced from cord blood, cord tissue, and placental tissue, targeting expectant parents who want to safeguard biological material against future medical need. Over 22 years of operation, AlphaCord reports processing and storing samples for 350,000+ families and operates an asset-light model in which all laboratory processing and cryogenic storage are executed by partner CryoPoint, an AABB-accredited, FDA-registered, CLIA-registered, and HIPAA-compliant facility. Core technology centers on manual processing using a modified Rubinstein technique—which the company claims yields higher stem cell recovery rates and reduced red blood cell contamination versus automated processing—combined with vapor phase liquid nitrogen storage at approximately -196°C with 24/7 temperature monitoring and backup generator systems.

The product portfolio consists of three core banking packages (Cord Blood; Cord Blood + Cord Tissue; Cord Blood + Cord Tissue + Placenta), each available as an annual plan or a 20-year prepaid plan, with first-year storage bundled into initial fees and recurring annual storage fees billed thereafter ($150-$400 depending on package). Pricing ranges from $81/month for the entry annual cord blood plan to $747/month for the comprehensive 20-year prepaid bundle, with an upfront payment option and a $59 5-Chamber Storage Bag add-on that segments a single collection into up to five treatment-ready units. Revenue mechanics combine an upfront processing-and-collection license fee with a multi-decade recurring storage annuity, and prepaid plans function as long-duration contract liabilities on the balance sheet.

Distribution is direct-to-consumer via the company's e-commerce website and a phone-based inside sales team, supplemented by a gift registry feature that allows extended family to contribute toward fees and a referral program offering $150 bilateral credit. Marketing is content-led, with SEO-optimized educational content, downloadable information kits, and a 4.8-star Google review profile serving as social proof. Customer segments include general expectant parents, families with medical histories of treatable blood disorders or cancers, and ethnically diverse families facing lower odds of finding matched public- registry donors. The regulatory perimeter requires multi-state licensure (New Jersey, New York, Illinois) in addition to federal-level FDA registration and AABB accreditation, and the company backs its service with an $85,000 quality guarantee if stored stem cells fail to engraft.

Short descriptiontext

AlphaCord is a privately held U.S. cord blood and tissue banking company founded in 2002 that sells direct-to-consumer cryogenic stem cell preservation services to expectant parents, with 350,000+ samples processed through partner CryoPoint laboratory and AABB-accredited, FDA-registered operations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersScottsdale, United States
HQ citystring
Scottsdale
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cord blood banking, stem cell storage, cord tissue banking, newborn stem cells, cryogenic preservation
Industry1 code
PRIMARYHLAAAGAE
Cell & Tissue Banking (biobanking, cord blood/tissue)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
NAICS code1 code
  • Blood and Organ Banks621991
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Stem Cell Banking
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Stem Cell Banking Services
TypeSubscription Recurring
Description

One-time initial fees covering collection kit, processing, testing, and first year storage. Recurring annual storage fees for ongoing cryogenic preservation. Optional prepaid multi-year storage plans (20 years) at discounted rates. Additional upsell: 5-chamber storage bag option for $59.

alphacord.com
2Collection and Processing Services
TypeOne Time License
Description

Initial service fees include complete collection kit, priority shipping, world-class processing, and quality testing. First year storage included in initial package pricing.

alphacord.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Personnel, Marketing or Sales, Supply Chain, Technology or R&D
Pricing details7 tiers
1Cord Blood Annual Plan - 12 month payment
ModelSubscriptionBilling cadenceMonthly
Notes

$81/month for 12 months ($972 total). First year storage included. Annual renewal storage fee $150/year after first year. Upfront payment option: $850 annually.

alphacord.com
2Cord Blood 20-Year Prepaid Plan
ModelSubscriptionBilling cadenceMonthly
Notes

$298/month for 12 months. Upfront payment: $3,400. Includes 20 years of storage.

alphacord.com
3Cord Blood & Tissue Annual Plan - 12 month payment
ModelSubscriptionBilling cadenceMonthly
Notes

$116/month for 12 months ($1,392 total). First year storage included. Annual renewal storage fee $300/year after first year. Upfront payment option: $1,278 annually.

alphacord.com
4Cord Blood & Tissue 20-Year Prepaid Plan
ModelSubscriptionBilling cadenceMonthly
Notes

$546/month for 12 months. Upfront payment: $6,378. Includes 20 years of storage.

alphacord.com
5Cord Blood, Tissue & Placenta Annual Plan - 12 month payment
ModelSubscriptionBilling cadenceMonthly
Notes

$142/month for 12 months ($1,704 total). First year storage included. Annual renewal storage fee $400/year after first year. Upfront payment option: $1,588 annually.

alphacord.com
6Cord Blood, Tissue & Placenta 20-Year Prepaid Plan
ModelSubscriptionBilling cadenceMonthly
Notes

$747/month for 12 months. Upfront payment: $8,788. Includes 20 years of storage.

alphacord.com
75-Chamber Storage Bag Add-on
ModelUnit PricingBilling cadenceMonthly
Notes

$59 additional for 5-chamber storage bag option that enables up to 5 treatments from a single collection.

alphacord.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

AlphaCord provides private newborn stem cell banking services for expectant parents, including the collection, processing, and long-term cryogenic storage of cord blood, cord tissue, and placenta tissue stem cells. Customers enroll in annual or 20-year prepaid storage plans that include a collection kit, priority shipping, processing at the partner laboratory (CryoPoint), and quality testing with first-year storage included.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Over 40,000 patients worldwide have benefited from cord blood stem cell transplants
+4 more records
Product overview1 text field

AlphaCord is a cord blood and tissue banking company offering private stem cell storage services. The product portfolio consists of three core banking packages (Cord Blood, Cord Blood & Cord Tissue, and Cord Blood, Cord Tissue & Placenta) available in annual or 20-year prepaid storage plans. Each package includes collection kit, shipping, processing, and quality testing. An optional 5-Chamber Storage Bag enables multiple treatments from a single sample. Additional services include a Gift Registry for contributions toward banking fees and a Referral Program. The company stores hematopoietic stem cells from cord blood and mesenchymal stem cells from cord tissue and placenta for treatment of 80+ diseases and regenerative medicine applications.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or Integration
Description

CryoPoint is AlphaCord's partner state-of-the-art laboratory providing processing and cryogenic storage services. The laboratory is AABB accredited, HIPAA Compliant, and registered with the FDA. It ensures adherence to stringent industry standards and protocols for processing and banking cord blood and tissue stem cells. CryoPoint operates with full backup systems including battery and generator backup, with tanks electronically and manually monitored for temperature and liquid nitrogen levels.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Private cord blood and tissue bank positioned on affordability and innovation, with a product lineup very similar to AlphaCord's annual and prepaid storage plans.

TypeDirect peer
Description

Cord blood and placenta tissue banking service operating in the same DTC category as AlphaCord, with comparable product packaging and consumer-facing pricing.

TypeDirect peer
Description

Long-established private cord blood bank, now part of Revvity (formerly PerkinElmer). Competes head-to-head with AlphaCord on cord blood and tissue storage for expectant parents with a similar DTC and hospital-channel GTM.

TypeDirect peer
Description

Publicly traded cord blood banking company offering private and public menstrual stem cell services. Directly comparable service mix (cord blood + cord tissue) and similar DTC positioning.

TypeBroad incumbent
Description

Large, established public blood and cord blood banking organization. Not a direct pricing competitor but operates in the same biobanking category and shapes consumer perception of public vs. private banking.

TypeOthers
Description

Specialty logistics and cryogenic cold-chain provider for life sciences, including reproductive and cell therapy markets. Enabling infrastructure supplier relevant to AlphaCord's cold-chain and storage value chain.

TypeDirect peer
Description

Hybrid private/public cord blood bank with international operations (US, Taiwan). Comparable in core service offering; broader hybrid model adds public-banking adjacency.

TypeDirect peer
Description

One of the largest US private cord blood banking companies, owned by CooperSurgical. Offers nearly identical cord blood and tissue banking services and is the principal competitor AlphaCord benchmarks against on price.

TypeEmerging player
Description

Regenerative medicine company supplying perinatal and adult tissue-derived cell products. Comparable in category focus on birth-tissue-derived stem cells and adjacent to AlphaCord's long-term regenerative-medicine thesis.

10FamilyCord
TypeDirect peer
Description

Smaller private cord blood bank offering cord blood and tissue storage with comparable annual and long-term prepaid plans; smaller competitor with overlapping target customer.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Alpha Cord

Stem Cell Bankingalphacord.com

AlphaCord is a privately held U.S. cord blood and tissue banking company founded in 2002 that sells direct-to-consumer cryogenic stem cell preservation services to expectant parents, with 350,000+ samples processed through partner CryoPoint laboratory and AABB-accredited, FDA-registered operations.

What Alpha Cord does

AlphaCord, LLC is a privately held U.S. cord blood and tissue banking company founded in 2002 and headquartered in Scottsdale, Arizona. The company provides direct-to-consumer cryogenic preservation services for newborn stem cells sourced from cord blood, cord tissue, and placental tissue, targeting expectant parents who want to safeguard biological material against future medical need. Over 22 years of operation, AlphaCord reports processing and storing samples for 350,000+ families and operates an asset-light model in which all laboratory processing and cryogenic storage are executed by partner CryoPoint, an AABB-accredited, FDA-registered, CLIA-registered, and HIPAA-compliant facility. Core technology centers on manual processing using a modified Rubinstein technique—which the company claims yields higher stem cell recovery rates and reduced red blood cell contamination versus automated processing—combined with vapor phase liquid nitrogen storage at approximately -196°C with 24/7 temperature monitoring and backup generator systems.

The product portfolio consists of three core banking packages (Cord Blood; Cord Blood + Cord Tissue; Cord Blood + Cord Tissue + Placenta), each available as an annual plan or a 20-year prepaid plan, with first-year storage bundled into initial fees and recurring annual storage fees billed thereafter ($150-$400 depending on package). Pricing ranges from $81/month for the entry annual cord blood plan to $747/month for the comprehensive 20-year prepaid bundle, with an upfront payment option and a $59 5-Chamber Storage Bag add-on that segments a single collection into up to five treatment-ready units. Revenue mechanics combine an upfront processing-and-collection license fee with a multi-decade recurring storage annuity, and prepaid plans function as long-duration contract liabilities on the balance sheet.

Distribution is direct-to-consumer via the company's e-commerce website and a phone-based inside sales team, supplemented by a gift registry feature that allows extended family to contribute toward fees and a referral program offering $150 bilateral credit. Marketing is content-led, with SEO-optimized educational content, downloadable information kits, and a 4.8-star Google review profile serving as social proof. Customer segments include general expectant parents, families with medical histories of treatable blood disorders or cancers, and ethnically diverse families facing lower odds of finding matched public- registry donors. The regulatory perimeter requires multi-state licensure (New Jersey, New York, Illinois) in addition to federal-level FDA registration and AABB accreditation, and the company backs its service with an $85,000 quality guarantee if stored stem cells fail to engraft.

Alpha Cord firmographics

Firmographics
Name
Alpha Cord
Legal name
AlphaCord, LLC
Website
https://alphacord.com
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
11–50 employees
Short description
AlphaCord is a privately held U.S. cord blood and tissue banking company founded in 2002 that sells direct-to-consumer cryogenic stem cell preservation services to expectant parents, with 350,000+ samples processed through partner CryoPoint laboratory and AABB-accredited, FDA-registered operations.
Ownership category
akta.pro rank

Alpha Cord industry classification

Industry
Product category
Stem Cell Banking
NAICS
Blood and Organ Banks (621991)
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAAAGAE
Cell & Tissue Banking (biobanking, cord blood/tissue)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering

Keywords

  • Cord blood banking
  • Stem cell storage
  • Cord tissue banking
  • Newborn stem cells
  • Cryogenic preservation

Where Alpha Cord is headquartered

Location

Headquarters

HQ city
Scottsdale
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Alpha Cord business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Operations, Personnel, Marketing or Sales, Supply Chain, Technology or R&D

Revenue model

  1. Stem Cell Banking Services: One-time initial fees covering collection kit, processing, testing, and first year storage. Recurring annual storage fees for ongoing cryogenic preservation. Optional prepaid multi-year storage plans (20 years) at discounted rates. Additional upsell: 5-chamber storage bag option for $59.
  2. Collection and Processing Services: Initial service fees include complete collection kit, priority shipping, world-class processing, and quality testing. First year storage included in initial package pricing.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyCord Blood Annual Plan - 12 month payment
SubscriptionMonthlyCord Blood 20-Year Prepaid Plan
SubscriptionMonthlyCord Blood & Tissue Annual Plan - 12 month payment
SubscriptionMonthlyCord Blood & Tissue 20-Year Prepaid Plan
SubscriptionMonthlyCord Blood, Tissue & Placenta Annual Plan - 12 month payment
SubscriptionMonthlyCord Blood, Tissue & Placenta 20-Year Prepaid Plan
Unit PricingMonthly5-Chamber Storage Bag Add-on

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Alpha Cord product offering

Product offering

Core offering

AlphaCord provides private newborn stem cell banking services for expectant parents, including the collection, processing, and long-term cryogenic storage of cord blood, cord tissue, and placenta tissue stem cells. Customers enroll in annual or 20-year prepaid storage plans that include a collection kit, priority shipping, processing at the partner laboratory (CryoPoint), and quality testing with first-year storage included.

Product overview

AlphaCord is a cord blood and tissue banking company offering private stem cell storage services. The product portfolio consists of three core banking packages (Cord Blood, Cord Blood & Cord Tissue, and Cord Blood, Cord Tissue & Placenta) available in annual or 20-year prepaid storage plans. Each package includes collection kit, shipping, processing, and quality testing. An optional 5-Chamber Storage Bag enables multiple treatments from a single sample. Additional services include a Gift Registry for contributions toward banking fees and a Referral Program. The company stores hematopoietic stem cells from cord blood and mesenchymal stem cells from cord tissue and placenta for treatment of 80+ diseases and regenerative medicine applications.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • Over 40,000 patients worldwide have benefited from cord blood stem cell transplants
  • +4 more outcomes

Companies that use Alpha Cord

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Alpha Cord technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Alpha Cord partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • CryoPoint (Partner Laboratory)coreTechnology or IntegrationCryoPoint is AlphaCord's partner state-of-the-art laboratory providing processing and cryogenic storage services. The laboratory is AABB accredited, HIPAA Compliant, and registered with the FDA. It ensures adherence to stringent industry standards and protocols for processing and banking cord blood and tissue stem cells. CryoPoint operates with full backup systems including battery and generator backup, with tanks electronically and manually monitored for temperature and liquid nitrogen levels.

Scale indicators7 records

Recent moves5 records

Expansion highlights4 records

Alpha Cord competitors and assessment

Company assessment

Direct peers

  • Americord Registry: Private cord blood and tissue bank positioned on affordability and innovation, with a product lineup very similar to AlphaCord's annual and prepaid storage plans.
  • LifebankUSA: Cord blood and placenta tissue banking service operating in the same DTC category as AlphaCord, with comparable product packaging and consumer-facing pricing.
  • ViaCord: Long-established private cord blood bank, now part of Revvity (formerly PerkinElmer). Competes head-to-head with AlphaCord on cord blood and tissue storage for expectant parents with a similar DTC and hospital-channel GTM.
  • Cryo-Cell International: Publicly traded cord blood banking company offering private and public menstrual stem cell services. Directly comparable service mix (cord blood + cord tissue) and similar DTC positioning.
  • StemCyte: Hybrid private/public cord blood bank with international operations (US, Taiwan). Comparable in core service offering; broader hybrid model adds public-banking adjacency.
  • Cord Blood Registry (CBR): One of the largest US private cord blood banking companies, owned by CooperSurgical. Offers nearly identical cord blood and tissue banking services and is the principal competitor AlphaCord benchmarks against on price.
  • FamilyCord: Smaller private cord blood bank offering cord blood and tissue storage with comparable annual and long-term prepaid plans; smaller competitor with overlapping target customer.

Broad incumbents

  • New York Blood Center: Large, established public blood and cord blood banking organization. Not a direct pricing competitor but operates in the same biobanking category and shapes consumer perception of public vs. private banking.

Others

  • Cryoport Systems: Specialty logistics and cryogenic cold-chain provider for life sciences, including reproductive and cell therapy markets. Enabling infrastructure supplier relevant to AlphaCord's cold-chain and storage value chain.

Emerging players

  • OrganaBio: Regenerative medicine company supplying perinatal and adult tissue-derived cell products. Comparable in category focus on birth-tissue-derived stem cells and adjacent to AlphaCord's long-term regenerative-medicine thesis.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Alpha Cord social profiles

Digital presence

Alpha Cord compliance and trust

Trust signal

Compliance6 records

Alpha Cord financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Alpha Cord leadership team

Management profile

Number of profiles

Alpha Cord funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Alpha Cord M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alpha Cord

What does Alpha Cord do?

AlphaCord provides private newborn stem cell banking services for expectant parents, including the collection, processing, and long-term cryogenic storage of cord blood, cord tissue, and placenta tissue stem cells. Customers enroll in annual or 20-year prepaid storage plans that include a collection kit, priority shipping, processing at the partner laboratory (CryoPoint), and quality testing with first-year storage included.

Is Alpha Cord a public or private company?

Alpha Cord is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Alpha Cord founded?

Alpha Cord was founded in 2002. It employs 11 to 50 people.

Where is Alpha Cord based?

Alpha Cord is headquartered in Scottsdale, United States, in the North America region.

How does Alpha Cord make money?

Two revenue lines are on record. Stem Cell Banking Services are the primary driver. The others are collection and Processing Services.

Who are Alpha Cord's main competitors?

Direct peers on record are Americord Registry, LifebankUSA, ViaCord, Cryo-Cell International, StemCyte, Cord Blood Registry (CBR) and FamilyCord. New York Blood Center is listed as a broad incumbent. Cryoport Systems is listed as an others. OrganaBio is listed as an emerging player.

Does Alpha Cord have an API?

No public API is recorded for Alpha Cord.

What industry is Alpha Cord in?

Alpha Cord's product category is Stem Cell Banking. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue). Its NAICS code is 621991 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales